These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8385601)

  • 21. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.
    Handley DA; Van Valen RG; Saunders RN
    Immunopharmacology; 1986 Jun; 11(3):175-82. PubMed ID: 3733419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary disease.
    Marr KA; Fairbairn SM; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 1996 Jun; 19(3):233-7. PubMed ID: 8803882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.
    Bailey SR; Adair HS; Reinemeyer CR; Morgan SJ; Brooks AC; Longhofer SL; Elliott J
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):167-73. PubMed ID: 19091426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
    Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
    J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
    Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
    Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PAF receptor antagonist, BN 52021, attenuates thromboxane release and improves survival in lethal canine endotoxemia.
    Moore JM; Earnest MA; DiSimone AG; Abumrad NN; Fletcher JR
    Circ Shock; 1991 Sep; 35(1):53-9. PubMed ID: 1660355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
    Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxin-induced changes in rat mesenteric microcirculation.
    Li SH; Fei X; Gong XQ; Wu ZL
    Yao Xue Xue Bao; 1991; 26(1):6-9. PubMed ID: 1887797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
    Doebber TW; Wu MS; Robbins JC; Choy BM; Chang MN; Shen TY
    Biochem Biophys Res Commun; 1985 Mar; 127(3):799-808. PubMed ID: 2985058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X; Han GQ; Li RZ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):672-6. PubMed ID: 2983307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
    Hussaini IM; Shen TY
    Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor.
    Wang H; Tan X; Chang H; Gonzalez-Crussi F; Remick DG; Hsueh W
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):603-8. PubMed ID: 9065783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.
    Yokota Y; Inamura N; Asano M; Yamamoto Y; Nakahara K; Notsu Y; Ono T; Watanabe M
    Eur J Pharmacol; 1994 Jun; 258(3):239-46. PubMed ID: 8088357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma.
    Stenzel H; Hümmer B; Hahn HL
    Agents Actions Suppl; 1987; 21():253-60. PubMed ID: 2823582
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.